Activation of Toll‐like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients-Reference-Cited by-同舟云学术

Activation of Toll‐like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients

Published:2018-11-28 Issue:1 Volume:196 Page:39-51
ISSN:0009-9104
Container-title:Clinical & Experimental Immunology
language:en
Short-container-title:Clin Exp Immunol

Author:

Shimizu T.¹^ORCID,Nakamura H.¹,Takatani A.¹,Umeda M.¹,Horai Y.²,Kurushima S.³,Michitsuji T.⁴,Nakashima Y.⁵,Kawakami A.¹

Affiliation:

1. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

2. Clinical Research Center National Hospital Organization Nagasaki Medical Center Omura Japan

3. Department of Rheumatology Sasebo Chuo Hospital Sasebo Japan

4. Department of General and Internal Medicine National Hospital Organization Nagasaki Medical Center Omura Japan

5. Department of Rheumatology Sasebo City Medical Center Sasebo Japan

Funder

JSPS KAKENHI

Publisher

Oxford University Press (OUP)

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cei.13242

Reference30 articles.

1. Primary Sjogren's syndrome: new clinical and therapeutic concepts

2. Activation of the Interferon Pathway in Peripheral Blood of Patients with Sjögren’s Syndrome

3. Activation of the type I interferon pathway in primary Sjögren's syndrome

4. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren’s syndrome

5. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review of Sjögren's syndrome: Classification criteria, risk factors, and signaling pathways;Heliyon;2024-09

2. Artesunate alleviates Sjögren's Syndrome by inhibiting the interferon-α signaling in plasmacytoid dendritic cells via TLR-MyD88-IRF7;Biomedicine & Pharmacotherapy;2024-08

3. Amplified Type I Interferon Response in Sjögren's Disease via Ectopic Toll‐Like Receptor 7 Expression in Salivary Gland Epithelial Cells Induced by Lysosome‐Associated Membrane Protein 3;Arthritis & Rheumatology;2024-06-04

4. Emerging biologic frontiers for Sjogren’s syndrome: Unveiling novel approaches with emphasis on extra glandular pathology;Frontiers in Pharmacology;2024-05-17

5. Elevated expression of Toll-like receptor 7 and its correlation with clinical features in patients with primary Sjögren’s syndrome;Advances in Rheumatology;2024-03-04